Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Cognitive disorder
ADR ID BADD_A05519
ADR Hierarchy
17      Nervous system disorders
17.03      Mental impairment disorders
17.03.03      Mental impairment (excl dementia and memory loss)
17.03.03.003      Cognitive disorder
19      Psychiatric disorders
19.21      Cognitive and attention disorders and disturbances
19.21.02      Cognitive and attention disorders and disturbances NEC
19.21.02.001      Cognitive disorder
Description Diminished or impaired mental and/or intellectual function. [MeSH]
MedDRA Code 10057668
MeSH ID D060825
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Cognitive deterioration | Cognitive disorder NEC | Cognitive disturbance | Cognitive impairment | Cognitive disorders | Cognitive function abnormal | Cognitive disorder NEC aggravated | Cognitive disorder | Minor cognitive motor disorder | Mild neurocognitive disorder | Neurocognitive deficit | Cognitive slowing | Cognitive Dysfunction | Cognitive Dysfunctions | Dysfunction, Cognitive | Dysfunctions, Cognitive | Cognitive Impairments | Cognitive Impairment | Impairment, Cognitive | Impairments, Cognitive | Mild Cognitive Impairment | Cognitive Impairment, Mild | Cognitive Impairments, Mild | Impairment, Mild Cognitive | Impairments, Mild Cognitive | Mild Cognitive Impairments | Mild Neurocognitive Disorder | Disorder, Mild Neurocognitive | Disorders, Mild Neurocognitive | Mild Neurocognitive Disorders | Neurocognitive Disorder, Mild | Neurocognitive Disorders, Mild | Cognitive Decline | Cognitive Declines | Decline, Cognitive | Declines, Cognitive | Mental Deterioration | Deterioration, Mental | Deteriorations, Mental | Mental Deteriorations
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00898Finasteride0.021576%
BADD_D00932Fluoxetine0.000157%
BADD_D00933Fluoxetine hydrochloride--
BADD_D00948Fluvastatin0.001630%
BADD_D00949Fluvastatin sodium--
BADD_D00962Fosaprepitant--
BADD_D00963Fosaprepitant dimeglumine--
BADD_D00981Gabapentin0.000571%
BADD_D00982Gabapentin enacarbil-
BADD_D00985Gadodiamide0.014227%
BADD_D00996Galantamine0.002166%
BADD_D01008Gefitinib0.000168%
BADD_D01032Glycerol phenylbutyrate0.004312%
BADD_D01038Goserelin0.000667%
BADD_D01083Hydrochlorothiazide--
BADD_D01086Hydrocortisone--
BADD_D01096Hydromorphone--
BADD_D01103Hydroxychloroquine--
BADD_D01120Ibuprofen--
BADD_D01142Imiquimod0.001097%
BADD_D01194Irbesartan0.000126%
BADD_D01217Itraconazole0.004008%
BADD_D01222Ixabepilone--
BADD_D01223Ixazomib0.001903%
BADD_D01238Lacosamide0.014773%
BADD_D01240Lactulose0.000268%
BADD_D01243Lamotrigine0.001060%
BADD_D01245Lansoprazole--
BADD_D01257Letrozole0.001686%
BADD_D01258Leucovorin0.001859%
The 3th Page    First    Pre   3 4 5 6 7    Next   Last    Total 8 Pages
ADReCS-Target
ADR Term Drug Name Target